[Severe panuveitis in a metastatic cutaneous melanoma patient treated with vemurafenib]

J Fr Ophtalmol. 2018 Jun;41(6):e291-e292. doi: 10.1016/j.jfo.2017.10.019. Epub 2018 Jun 13.

[Article in French]

Authors

M Boiché¹, J-B Conart², K Angioi-Duprez²

Affiliations

¹ Département d'ophtalmologie, CHRU Nancy-Brabois, rue du Morvan, 54500 Vandoeuvre-les-Nancy, France. Electronic address: [email protected].
² Département d'ophtalmologie, CHRU Nancy-Brabois, rue du Morvan, 54500 Vandoeuvre-les-Nancy, France.

PMID: 29908650
DOI: 10.1016/j.jfo.2017.10.019

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Dose-Response Relationship, Drug
Female
Humans
Melanoma / drug therapy*
Melanoma / pathology
Neoplasm Metastasis
Panuveitis / chemically induced*
Panuveitis / diagnosis
Panuveitis / drug therapy
Panuveitis / pathology
Prednisone / administration & dosage
Severity of Illness Index
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology
Vemurafenib / administration & dosage
Vemurafenib / adverse effects*
Visual Acuity / drug effects

Substances

Vemurafenib
Prednisone